Physician profile
David C Johns
NPI 1407851850
$2,278.63
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,279.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.69 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $327.78 | 2019 | |
| Lilly USA, LLC | $215.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $205.72 | 2019 | |
| Amarin Pharma, INC. | $185.53 | 2019 | |
| Novo Nordisk INC | $157.78 | 2019 | |
| Pfizer INC. | $152.66 | 2019 | |
| Allergan, INC. | $83.97 | 2019 | |
| Glaxosmithkline, LLC. | $77.13 | 2019 | |
| Abbvie INC. | $65.21 | 2019 | |
| Merck Sharp & Dohme LLC | $62.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.41 | 2019 | |
| Horizon Therapeutics Plc | $56.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.23 | 2019 | |
| Hikma Pharmaceuticals USA | $44.82 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $29.65 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $28.46 | 2019 | |
| Shire North American Group INC | $18.36 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.98 | 2019 | |
| Seqirus USA INC | $14.46 | 2019 | |
| Sanofi Pasteur INC. | $14.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Johns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.